97 related articles for article (PubMed ID: 37400142)
1. Genetic Characterization of Pediatric Mixed Phenotype Acute Leukemia (MPAL).
Panagopoulos I; Andersen K; Johannsdottir IMR; Tandsæther MR; Micci F; Heim S
Cancer Genomics Proteomics; 2024; 21(1):1-11. PubMed ID: 38151288
[TBL] [Abstract][Full Text] [Related]
2. Pathogenetic Dichotomy in Angioleiomyoma.
Panagopoulos I; Andersen K; Brunetti M; Gorunova L; Kostolomov I; Kildal W; Hognestad HR; Lobmaier I; Micci F; Heim S
Cancer Genomics Proteomics; 2023; 20(6):556-566. PubMed ID: 37889065
[TBL] [Abstract][Full Text] [Related]
3. Genomic and global gene expression profiling in pediatric and young adult acute leukemia with PICALM::MLLT10 Fusion.
Ma J; Liu YC; Voss RK; Ma J; Palagani A; Caldwell E; Rosikiewicz W; Cardenas M; Foy S; Umeda M; Wilkinson MR; Inaba H; Klco JM; Rubnitz JE; Wang L
Leukemia; 2024 May; 38(5):981-990. PubMed ID: 38429501
[TBL] [Abstract][Full Text] [Related]
4. Treatment outcomes of childhood PICALM::MLLT10 acute leukaemias.
Mark C; Meshinchi S; Joyce B; Gibson B; Harrison C; Bergmann AK; Goemans BF; Pronk CJH; Lapillonne H; Leverger G; Antoniou E; Schneider M; Attarbaschi A; Dworzak M; Stary J; Tomizawa D; Ebert S; Lejman M; Kolb EA; Schmiegelow K; Hasle H; Abla O
Br J Haematol; 2024 Feb; 204(2):576-584. PubMed ID: 37743097
[TBL] [Abstract][Full Text] [Related]
5. Structural variants involving MLLT10 fusion are associated with adverse outcomes in pediatric acute myeloid leukemia.
Abla O; Ries RE; Triche T; Gerbing RB; Hirsch B; Raimondi S; Cooper T; Farrar JE; Buteyn N; Harmon LM; Wen H; Deshpande AJ; Kolb EA; Gamis AS; Aplenc R; Alonzo T; Meshinchi S
Blood Adv; 2024 Apr; 8(8):2005-2017. PubMed ID: 38306602
[TBL] [Abstract][Full Text] [Related]
6. MLLT10 rearranged acute leukemia: Incidence, prognosis, and possible therapeutic strategies.
Forgione MO; McClure BJ; Yeung DT; Eadie LN; White DL
Genes Chromosomes Cancer; 2020 Jul; ():. PubMed ID: 32720323
[TBL] [Abstract][Full Text] [Related]
7. [Acute myeloid leukemia with positive PICAML-MLLT10 fusion gene: report of 4 cases and literature review].
Hu DY; Shen K; Guo YS; Chen SN
Zhonghua Xue Ye Xue Za Zhi; 2023 Aug; 44(8):687-689. PubMed ID: 37803846
[No Abstract] [Full Text] [Related]
8. Challenging our understanding of B-cell lymphomagenesis and risk: Paediatric high-grade B-cell lymphoma, not otherwise specified with a DDX3X::MLLT10 fusion and an IGH deletion.
Hare L; Trotman J; Tarpey P; Hook E; Burke GAA;
Pediatr Blood Cancer; 2024 Mar; 71(3):e30810. PubMed ID: 38102963
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic challenge in a case of ambiguous lineage acute leukemia with PICALM::MLLT10 rearrangement.
Quessada J; Petit A; Saultier P; Fenwarth L; Marceau-Renaut A; Arnoux I; Payet-Bornet D; Michel G; Lafage M; Loosveld M
Pediatr Blood Cancer; 2023 Nov; 70(11):e30573. PubMed ID: 37439579
[No Abstract] [Full Text] [Related]
10. A murine model of hnRNPH2-related neurodevelopmental disorder reveals a mechanism for genetic compensation by Hnrnph1.
Korff A; Yang X; O'Donovan K; Gonzalez A; Teubner BJ; Nakamura H; Messing J; Yang F; Carisey AF; Wang YD; Patni T; Sheppard H; Zakharenko SS; Chook YM; Taylor JP; Kim HJ
J Clin Invest; 2024 Apr; 134(8):. PubMed ID: 38618962
[No Abstract] [Full Text] [Related]
11. Sensory Processing in Children and Adolescents with Neurofibromatosis Type 1.
Pride NA; Haebich KM; Walsh KS; Lami F; Rouel M; Maier A; Chisholm AK; Lorenzo J; Hearps SJC; North KN; Payne JM
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509275
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Functional Promoter of Camel FGF21 Gene and Identification of Small Compounds Targeting FGF21 Protein.
Yong F; Yan M; Zhang L; Ji W; Zhao S; Gao Y
Vet Sci; 2023 Jul; 10(7):. PubMed ID: 37505857
[TBL] [Abstract][Full Text] [Related]
13. Neurofibromatosis Type 1-Associated Optic Pathway Gliomas: Current Challenges and Future Prospects.
Tang Y; Gutmann DH
Cancer Manag Res; 2023; 15():667-681. PubMed ID: 37465080
[TBL] [Abstract][Full Text] [Related]
14. TREC mediated oncogenesis in human immature T lymphoid malignancies preferentially involves ZFP36L2.
Balducci E; Steimlé T; Smith C; Villarese P; Feroul M; Payet-Bornet D; Kaltenbach S; Couronné L; Lhermitte L; Touzart A; Dourthe ME; Simonin M; Baruchel A; Dombret H; Ifrah N; Boissel N; Nadel B; Macintyre E; Cieslak A; Asnafi V
Mol Cancer; 2023 Jul; 22(1):108. PubMed ID: 37430263
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics Analysis of Novel Targets for Treating Cervical Cancer by Immunotherapy Based on Immune Escape.
Han YH; Ma DY; Lee SJ; Mao YY; Sun SY; Jin MH; Sun HN; Kwon T
Cancer Genomics Proteomics; 2023; 20(4):383-397. PubMed ID: 37400149
[TBL] [Abstract][Full Text] [Related]
16. Genetic Pathways in Peritoneal Mesothelioma Tumorigenesis.
Panagopoulos I; Andersen K; Brunetti M; Gorunova L; Davidson B; Lund-Iversen M; Micci F; Heim S
Cancer Genomics Proteomics; 2023; 20(4):363-374. PubMed ID: 37400148
[TBL] [Abstract][Full Text] [Related]
17. Localization of
Shigeto H; Miyata H; Ashizawa T; Iizuka A; Kikuchi Y; Hozumi C; Maeda C; Yamaguchi K; Yamamura S; Akiyama Y
Cancer Genomics Proteomics; 2023; 20(4):375-382. PubMed ID: 37400147
[TBL] [Abstract][Full Text] [Related]
18. Targeting Autophagy With the Synergistic Combination of Chloroquine and Rapamycin as a Novel Effective Treatment for Well-differentiated Liposarcoma.
Masaki N; Aoki Y; Obara K; Kubota Y; Bouvet M; Miyazaki J; Hoffman RM
Cancer Genomics Proteomics; 2023; 20(4):317-322. PubMed ID: 37400145
[TBL] [Abstract][Full Text] [Related]
19. Acute Undifferentiated Leukemia With a Balanced t(5;10)(q35;p12) Resulting in Fusion of
Panagopoulos I; Andersen K; Wik HS; Tandsæther MR; Micci F; Heim S
Cancer Genomics Proteomics; 2023; 20(4):354-362. PubMed ID: 37400142
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
